# IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania

> **NCT02541708** · PHASE3 · UNKNOWN · sponsor: **Ifakara Health Institute** · enrollment: 230 (actual)

## Conditions studied

- Iron-Deficiency Anemia

## Interventions

- **DRUG:** Ferric carboxymaltose
- **DRUG:** Ferrous sulfate + folic acid

## Key facts

- **NCT ID:** NCT02541708
- **Lead sponsor:** Ifakara Health Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02541708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02541708, "IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02541708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*